BamSEC and AlphaSense Join Forces
Learn More

Vera Therapeutics Inc. – Material Contracts

NASDAQ: VERA    
Share price (3/24/26): $39.75    
Market cap (3/24/26): $2.836 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.10
from 10-K 3 pages Vera Therapeutics, Inc. Non-Employee Director Compensation Policy Amended and Restated Effective January 1, 2026
12/34/56
EX-10.1
from 10-Q 32 pages Vera Therapeutics, Inc. 2024 Inducement Plan Adopted by the Compensation Committee of the Board of Directors: February 3, 2024 Amended by the Compensation Committee of the Board of Directors: August 28, 2024 Amended by the Compensation Committee of the Board of Directors: January 28, 2025 Amended and Restated by the Compensation Committee of the Board of Directors: September 19, 2025
12/34/56
EX-10.24
from 10-K 11 pages November 4, 2024 Jason Carter Re: Revised Employment Terms Dear Jason
12/34/56
EX-10.11
from 10-K 3 pages Vera Therapeutics, Inc. Non-Employee Director Compensation Policy Amended and Restated Effective January 1, 2025
12/34/56
EX-10.10
from 10-K 3 pages Vera Therapeutics, Inc. Non-Employee Director Compensation Policy Amended and Restated Effective May 2, 2024
12/34/56
EX-10.7
from 10-K 32 pages Vera Therapeutics, Inc. 2024 Inducement Plan Adopted by the Compensation Committee of the Board of Directors: February 3, 2024 Amended by the Compensation Committee of the Board of Directors: August 28, 2024 Amended by the Compensation Committee of the Board of Directors: January 28, 2025
12/34/56
EX-10.2
from 10-Q 33 pages Vera Therapeutics, Inc. 2024 Inducement Plan Adopted by the Compensation Committee of the Board of Directors: February 3, 2024 Amended by the Compensation Committee of the Board of Directors: August 28, 2024 1. General
12/34/56
EX-10.1
from 10-Q 52 pages June 26, 2024 Revised David Johnson Re: Employment Terms Dear David
12/34/56
EX-10.1
from 8-K 37 pages June 26, 2024 Revised David Johnson Re: Employment Terms Dear David
12/34/56
EX-10.3
from 10-Q 20 pages December 19, 2023 William Turner Re: Employment Terms Dear William
12/34/56
EX-10.2
from 10-Q 20 pages January 3, 2024 Robert Brenner, M.D. Re: Employment Terms Dear Robert
12/34/56
EX-10.14
from 10-K 10 pages Material contract
12/34/56
EX-10.11
from 10-K 3 pages Vera Therapeutics, Inc. Non-Employee Director Compensation Policy Amended and Restated Effective January 1, 2024
12/34/56
EX-10.9
from 10-K 6 pages Vera Therapeutics, Inc. 2024 Inducement Plan Restricted Stock Unit Grant Notice
12/34/56
EX-10.8
from 10-K 14 pages Vera Therapeutics, Inc. Stock Option Grant Notice
12/34/56
EX-10.7
from 10-K 32 pages Inducement Plan Vera Therapeutics, Inc. 2024 Inducement Plan Adopted by the Board of Directors: February 2, 2024
12/34/56
EX-10
from 10-K 3 pages Vera Therapeutics, Inc. Non-Employee Director Compensation Policy Amended and Restated March 28, 2023
12/34/56
EX-10.1
from 8-K 4 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”
12/34/56
EX-10.17
from S-1 4 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Amendment No. 1 to License Agreement
12/34/56
EX-10.16
from S-1 55 pages License Agreement
12/34/56